The Disposition of Ara-C and Its Metabolites
A Pharmacokinetic Simulation
Download eBook for Free
|PDF file||1.8 MB||
Use Adobe Acrobat Reader version 10 or higher for the best experience.
Purchase Print Copy
|Add to Cart||Paperback50 pages||$20.00||$16.00 20% Web Discount|
Describes a computer model of the pharmacokinetics of anticancer agents, and applies it to the drug cytosine arabinoside (ara-C), a major factor in the improved survival rate for adult leukemia. Although the model is applicable to any species, the authors concentrate on applying it to the experimental therapeutics of mouse leukemia. They show that ara-CTP — the metabolite of ara-C that is known to kill dividing cells or severely inhibit their rate of DNA synthesis — is present in tissue, after a single injection of ara-C, for times that are much longer than those estimated from ara-C levels alone. Thus, since the kinetics of ara-C and ara-CTP [in vivo] are quite different, the use of ara-C concentrations to predict states of the ara-CTP-dependent properties of toxicity or DNA inhibition can lead to large errors. The study also elaborates on the need for further measurements of certain enzyme levels (phosphatase) that are determinants of long ara-CTP halving time.
This report is part of the RAND Corporation Report series. The report was a product of the RAND Corporation from 1948 to 1993 that represented the principal publication documenting and transmitting RAND's major research findings and final research.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.